BRPI0922341A2 - composição farmacêutica revestida em fusão com liberação rápida. - Google Patents

composição farmacêutica revestida em fusão com liberação rápida.

Info

Publication number
BRPI0922341A2
BRPI0922341A2 BRPI0922341A BRPI0922341A BRPI0922341A2 BR PI0922341 A2 BRPI0922341 A2 BR PI0922341A2 BR PI0922341 A BRPI0922341 A BR PI0922341A BR PI0922341 A BRPI0922341 A BR PI0922341A BR PI0922341 A2 BRPI0922341 A2 BR PI0922341A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
fast release
coated pharmaceutical
melt coated
release melt
Prior art date
Application number
BRPI0922341A
Other languages
English (en)
Inventor
Lars Fahsel
Peter Kraahs
Stefanie Bold
Original Assignee
Losan Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Losan Pharma Gmbh filed Critical Losan Pharma Gmbh
Publication of BRPI0922341A2 publication Critical patent/BRPI0922341A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0922341A 2008-12-17 2009-12-17 composição farmacêutica revestida em fusão com liberação rápida. BRPI0922341A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08021917A EP2198859A1 (en) 2008-12-17 2008-12-17 Melt-coated pharmaceutical composition with fast release
PCT/EP2009/067371 WO2010070028A1 (en) 2008-12-17 2009-12-17 Melt-coated pharmaceutical composition with fast release

Publications (1)

Publication Number Publication Date
BRPI0922341A2 true BRPI0922341A2 (pt) 2016-01-12

Family

ID=40551928

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922341A BRPI0922341A2 (pt) 2008-12-17 2009-12-17 composição farmacêutica revestida em fusão com liberação rápida.

Country Status (6)

Country Link
US (1) US8481060B2 (pt)
EP (2) EP2198859A1 (pt)
BR (1) BRPI0922341A2 (pt)
CA (1) CA2746464A1 (pt)
RU (1) RU2554768C2 (pt)
WO (1) WO2010070028A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US8901113B2 (en) 2009-09-30 2014-12-02 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
EP2338480A1 (en) * 2009-12-22 2011-06-29 LEK Pharmaceuticals d.d. Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt
PH12012501992A1 (en) 2010-04-15 2013-01-14 Chromocell Corp Compounds, compositions, and methods for reducing or eliminating bitter taste
WO2012090218A1 (en) 2010-12-30 2012-07-05 Zota Health Care Ltd Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases
JP2014529630A (ja) 2011-09-07 2014-11-13 ザウラー−ブロシュ、ローラント 哺乳類の消化管における一つあるいは複数の物質の放出制御製剤
MX355775B (es) * 2011-10-20 2018-04-30 Chromocell Corp Compuestos, composiciones y metodos para reducir o eliminar el sabor amargo.
ES2691982T3 (es) 2012-11-30 2018-11-29 Acura Pharmaceuticals, Inc. Liberación autorregulada de un principio activo farmacéutico
HUE033723T2 (en) 2013-04-12 2018-01-29 Hermes Arzneimittel Gmbh An oral pharmaceutical composition comprising N-acetyl cysteine in taste
HRP20201863T1 (hr) 2014-06-20 2021-01-22 Hermes Arzneimittel Gmbh Oralni farmaceutski sastav sa zamaskiranim okusom
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CN112703015B (zh) * 2018-10-22 2024-03-22 Ioi油脂化学品有限责任公司 Hmc方法中使用的涂覆材料
RU2696573C1 (ru) * 2019-02-11 2019-08-06 Общество с ограниченной ответственностью "Квадрат-С" Противомикробный лекарственный препарат в форме таблеток фурацилина с ускоренным высвобождением

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07100665B2 (ja) * 1987-12-23 1995-11-01 信越化学工業株式会社 被覆薬剤の製造方法
DE3838094A1 (de) 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
NZ283160A (en) * 1994-05-06 1998-07-28 Pfizer Azithromycin in a controlled release dosage form for treating microbiol infections
PT841062E (pt) 1995-07-21 2005-03-31 Daiichi Seiyaku Co Processo para a producao de uma preparacao granular
AU3192700A (en) * 1999-03-17 2000-10-04 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
ATE341312T1 (de) * 2003-05-20 2006-10-15 Ethypharm Sa Orale pharmazeutische zusammensetzung mit verzögerter freisetzung
GB0330255D0 (en) * 2003-12-31 2004-02-04 Vectura Ltd Multiparticulate formulations for oral delivery
EP1891936A1 (de) 2006-08-18 2008-02-27 Losan Pharma GmbH Gut schluckbare pharmazeutische Zusammensetzung aus einem oder mehreren wirkstoffhaltigen Teilchen ohne unangenehmes Mundgefühl
US20090004285A1 (en) * 2007-06-29 2009-01-01 Liangping Yu Stable non-disintegrating dosage forms and method of making same

Also Published As

Publication number Publication date
EP2365801A1 (en) 2011-09-21
US8481060B2 (en) 2013-07-09
WO2010070028A1 (en) 2010-06-24
RU2554768C2 (ru) 2015-06-27
RU2011129213A (ru) 2013-01-27
CA2746464A1 (en) 2010-06-24
EP2198859A1 (en) 2010-06-23
US20110250244A1 (en) 2011-10-13

Similar Documents

Publication Publication Date Title
BRPI0922341A2 (pt) composição farmacêutica revestida em fusão com liberação rápida.
LTPA2018014I1 (lt) Farmacinė kompozicija 514
LTC2140867I2 (lt) Farmacinė kompozicija
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
DK2345410T3 (da) Farmaceutisk sammensætning til modificeret frigivelse
BRPI0721651A2 (pt) Composição farmacêutica
DE602008002756D1 (de) Bauzusammensetzung
ATE509022T1 (de) Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide
EP2299953A4 (en) MEDICAMENT COMPOSITION WITH DELAYED RELEASE
EP2381760A4 (en) CORN PROTEIN COMPOSITION
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
BRPI0812354A2 (pt) Composição farmacêutica não-aquosa.
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BRPI0917231A2 (pt) composição
DK2120884T3 (da) Farmaceutisk sammensætning
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0910901A2 (pt) composição farmacêutica com bisfosfonato
EP2112208A4 (en) COATING COMPOSITION
EP2236149A4 (en) MEDICAL COMPOSITION
BRPI0921313A2 (pt) composição farmaucêutica
PT2209464E (pt) Composição farmacêutica antimalárica
BRPI0922286A2 (pt) composto de quinolona e composição farmacêutica.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]